Table 1.
Clinicopathologic characteristics | Patients (n) | Percentage (%) |
---|---|---|
Gender | ||
Male | 8 | 9.3 |
Female | 78 | 90.7 |
Age, yr | 43.7 ± 10.3 | |
≥ 45 | 41 | 47.7 |
< 45 | 45 | 52.3 |
Tumor size, mm | 6.8 ± 2.2 | |
5 < and ≤ 10 | 58 | 67.4 |
≤ 5 | 28 | 32.6 |
Multifocality | ||
Multiple (≥ 2) | 5 | 5.8 |
Single | 81 | 94.2 |
Extrathyroid invasion | ||
Yes | 3 | 3.5 |
No | 83 | 96.5 |
Hashimoto’s disease | ||
Yes | 17 | 19.8 |
No | 69 | 80.2 |
Lymph node metastases | ||
Yes | 22 | 25.6 |
No | 64 | 74.4 |
T stage* | ||
T3 | 2 | 2.3 |
T1 | 84 | 97.7 |
BRAFV600E mutation | ||
Yes | 56 | 65.1 |
No | 30 | 34.9 |
TNM stage is based on the AJCC Cancer Staging Manual, 7th edition (2010).